How to Help Your Patients Save Money on Genvoya: A Provider's Guide to Savings Programs

Cost is one of the most common barriers HIV patients face in maintaining consistent Genvoya therapy. With a retail cash price of approximately $4,061–$5,146 per 30-day supply and no generic equivalent available in the U.S. as of 2026, even patients with insurance can face significant out-of-pocket expenses. This guide gives providers a complete roadmap to available savings programs and financial assistance resources.

Why Addressing Cost Is Part of Clinical Care

Adherence to ART is directly correlated with financial barriers. Studies consistently show that patients who face high out-of-pocket costs for antiretrovirals are at higher risk of medication gaps, missed doses, and treatment abandonment — all of which lead to viral rebound, potential resistance development, and worsening health outcomes. Proactively connecting patients to cost-reduction programs is not just helpful — it is part of providing high-quality HIV care.

Program 1: Gilead Advancing Access Copay Card (Commercially Insured Patients)

The Gilead Advancing Access Copay Card is the most impactful savings tool available for commercially insured Genvoya patients:

Benefit: Reduces patient out-of-pocket cost to as little as $0/month, with maximum annual savings of $7,200 per calendar year

Eligibility: Must have commercial (private) insurance. NOT available to patients with Medicare, Medicaid, CHIP, or other federal/state government programs.

Enrollment: Call 1-800-226-2056 or visit gileadadvancingaccess.com. Registration takes minutes; a card can be downloaded immediately or printed.

Clinical impact: Research from the Colorado Prescription Drug Affordability Board found that with commercial insurance and copay card access, the average patient paid just $119/month for Genvoya. Enrolling eligible patients from the start of therapy removes a major adherence barrier.

Program 2: Gilead Patient Assistance Program (Uninsured or Underinsured Patients)

For patients without insurance or with inadequate coverage, Gilead's Patient Assistance Program (PAP) provides Genvoya at no cost or significantly reduced cost:

Benefit: Free Genvoya for qualifying patients

Income thresholds: Generally, individual income below $40,000/year; household income below $100,000/year for families (thresholds may vary)

Enrollment: Call 1-800-226-2056. Provider signature on the application is required; your office will need to assist with enrollment.

Program 3: AIDS Drug Assistance Program (ADAP) — For Low-Income Patients

The AIDS Drug Assistance Program (ADAP), part of the Ryan White HIV/AIDS Program, is the single most important safety net for low-income HIV patients in the U.S. ADAPs exist in every state and can provide Genvoya at no cost to qualifying patients:

Eligibility: Typically up to 300–400% of the federal poverty level (varies by state); must be uninsured or underinsured

Access: Most Ryan White-funded clinics have patient navigators who handle ADAP enrollment. Refer patients to your local Ryan White grantee or direct them to HRSA's HIV Care Locator at habservice.hrsa.gov.

ADAP as insurance: In many states, ADAP also provides premium assistance to help uninsured HIV patients get and maintain private insurance — which then enables access to the Gilead copay card.

Program 4: Good Days Patient Assistance

Good Days offers copay assistance for specialty medications including HIV drugs. Eligibility requires insurance and a valid prescription. Contact: 1-877-968-7233 or mygooddays.org. While the benefit varies, this can be a useful supplemental program for patients who have insurance but still face significant copays after the Gilead card.

Navigating Prior Authorization for Genvoya

Most commercial and Medicare Part D plans require prior authorization (PA) for Genvoya. Failure to secure PA — or PA lapses — are a leading cause of treatment disruptions and cost escalation. Best practices for PA management:

Submit the initial PA at the same time as the prescription to minimize delays at the pharmacy

Include documentation of HIV diagnosis, viral load suppression data, and clinical rationale for Genvoya vs. alternative regimens

Track PA expiration dates in your EHR and initiate renewal 60+ days before expiration

Use Gilead Advancing Access case managers to help navigate PA appeals when denials occur

Handling Step Therapy Requirements

Some payers impose step therapy requirements for Genvoya, requiring documentation that Biktarvy or another preferred agent was tried first. When Genvoya is the clinically appropriate choice — for example, in patients with tolerance issues with other regimens, specific drug interaction profiles, or insurance plan formulary considerations — document the clinical rationale thoroughly. Many states have step therapy override laws that protect patients' right to access the medication their provider has prescribed; be familiar with your state's protections.

Helping Patients Find Genvoya When Cost Causes Them to Delay Filling

Even after cost assistance is arranged, patients sometimes face difficulty locating a pharmacy with Genvoya in stock. medfinder for providers is a service that contacts pharmacies on the patient's behalf to identify which ones have the medication in stock — particularly useful when patients are transitioning between pharmacies or experiencing a specialty pharmacy routing issue.

Practical Integration into Your Practice Workflow

To make savings program enrollment routine rather than reactive, consider:

Adding a financial screening step at every new HIV patient intake

Enrolling all commercially insured Genvoya patients in the Advancing Access Copay Card at the time of first prescription

Referring low-income, uninsured, or underinsured patients to your local Ryan White program or ADAP immediately at diagnosis

Designating a care coordinator or patient navigator to manage PA renewals, assistance program renewals, and financial screening annually

See also: How to help your patients find Genvoya in stock: A provider's guide for a complementary operational guide on access navigation.